PATENT CLAIM ANALYSIS

Application Number: 15974217
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "328000"]

Abstract:
Provided are in vitro and in vivo methods for determining whether a patient with Fabry disease will respond to treatment with a specific pharmacological chaperone.

Claim (Index 54):
The method of  claim 53 , wherein the 1-deoxygalactonojirimycin or salt thereof is administered to the patient every other day.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 93.0
- Lexical Diversity: 1.13043
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13445338', '14641707', '15338923', '15974222', '11749512']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.818891477524532
- 35 USC 102 Novelty (BERT): 0.5850131861534614
- Combined Prediction Score: 0.7955036483874249
- Mean Citation Score: 488.134856
- Max Citation Score: 521.381
- Similarity Product: 385.3329215600489

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test